ID   IDH_ECOLI               Reviewed;         416 AA.
AC   P08200;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   15-MAR-2017, entry version 161.
DE   RecName: Full=Isocitrate dehydrogenase [NADP];
DE            Short=IDH;
DE            EC=1.1.1.42;
DE   AltName: Full=IDP;
DE   AltName: Full=NADP(+)-specific ICDH;
DE   AltName: Full=Oxalosuccinate decarboxylase;
GN   Name=icd; Synonyms=icdA, icdE; OrderedLocusNames=b1136, JW1122;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3112144;
RA   Thorsness P.E., Koshland D.E. Jr.;
RT   "Inactivation of isocitrate dehydrogenase by phosphorylation is
RT   mediated by the negative charge of the phosphate.";
RL   J. Biol. Chem. 262:10422-10425(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A.,
RA   Ikemoto K., Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K.,
RA   Kimura S., Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K.,
RA   Mori H., Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N.,
RA   Sampei G., Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y.,
RA   Yano M., Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-414.
RC   STRAIN=CH734;
RX   PubMed=9352899; DOI=10.1128/jb.179.21.6551-6559.1997;
RA   Wang F.-S., Whittam T.S., Selander R.K.;
RT   "Evolutionary genetics of the isocitrate dehydrogenase gene (icd) in
RT   Escherichia coli and Salmonella enterica.";
RL   J. Bacteriol. 179:6551-6559(1997).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [7]
RP   ENZYME KINETICS, AND MUTAGENESIS OF TYR-160 AND LYS-230.
RX   PubMed=7819221; DOI=10.1021/bi00001a046;
RA   Lee M.E., Dyer D.H., Klein O.D., Bolduc J.M., Stoddard B.L.,
RA   Koshland D.E. Jr.;
RT   "Mutational analysis of the catalytic residues lysine 230 and tyrosine
RT   160 in the NADP(+)-dependent isocitrate dehydrogenase from Escherichia
RT   coli.";
RL   Biochemistry 34:378-384(1995).
RN   [8]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.M800187-MCP200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [10]
RP   CATALYTIC ACTIVITY, SUCCINYLATION AT LYS-100 AND LYS-242, AND
RP   MUTAGENESIS OF LYS-100 AND LYS-242.
RC   STRAIN=K12;
RX   PubMed=21151122; DOI=10.1038/nchembio.495;
RA   Zhang Z., Tan M., Xie Z., Dai L., Chen Y., Zhao Y.;
RT   "Identification of lysine succinylation as a new post-translational
RT   modification.";
RL   Nat. Chem. Biol. 7:58-63(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH ISOCITRATE AND
RP   MAGNESIUM, PHOSPHORYLATION AT SER-113, AND MUTAGENESIS OF SER-113.
RX   PubMed=2204109; DOI=10.1126/science.2204109;
RA   Hurley J.H., Dean A.M., Sohl J.L., Koshland D.E. Jr., Stroud R.M.;
RT   "Regulation of an enzyme by phosphorylation at the active site.";
RL   Science 249:1012-1016(1990).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH ISOCITRATE; NADP
RP   AND MAGNESIUM, MUTAGENESIS OF TYR-160 AND LYS-230, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=7761851; DOI=10.1126/science.7761851;
RA   Bolduc J.M., Dyer D.H., Scott W.G., Singer P., Sweet R.M.,
RA   Koshland D.E. Jr., Stoddard B.L.;
RT   "Mutagenesis and Laue structures of enzyme intermediates: isocitrate
RT   dehydrogenase.";
RL   Science 268:1312-1318(1995).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH NADP, AND
RP   SUBUNIT.
RX   PubMed=2682654; DOI=10.1073/pnas.86.22.8635;
RA   Hurley J.H., Thorsness P.E., Ramalingam V., Helmers N.H.,
RA   Koshland D.E. Jr., Stroud R.M.;
RT   "Structure of a bacterial enzyme regulated by phosphorylation,
RT   isocitrate dehydrogenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8635-8639(1989).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF MUTANT MET-230.
RX   PubMed=10623532; DOI=10.1006/jmbi.1999.3195;
RA   Cherbavaz D.B., Lee M.E., Stroud R.M., Koshland D.E. Jr.;
RT   "Active site water molecules revealed in the 2.1 A resolution
RT   structure of a site-directed mutant of isocitrate dehydrogenase.";
RL   J. Mol. Biol. 295:377-385(2000).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF MUTANT GLU-113 IN COMPLEX
RP   WITH SUBSTRATE ANALOG; MAGNESIUM AND NADP.
RX   PubMed=11284679; DOI=10.1021/bi002533q;
RA   Doyle S.A., Beernink P.T., Koshland D.E. Jr.;
RT   "Structural basis for a change in substrate specificity: crystal
RT   structure of S113E isocitrate dehydrogenase in a complex with
RT   isopropylmalate, Mg2+, and NADP.";
RL   Biochemistry 40:4234-4241(2001).
CC   -!- CATALYTIC ACTIVITY: Isocitrate + NADP(+) = 2-oxoglutarate + CO(2)
CC       + NADPH. {ECO:0000269|PubMed:21151122}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Binds 1 Mg(2+) or Mn(2+) ion per subunit.;
CC   -!- ENZYME REGULATION: Inhibition of this enzyme by phosphorylation
CC       regulates the branch point between the Krebs cycle and the
CC       glyoxylate bypass, which is an alternate route that accumulates
CC       carbon for biosynthesis when acetate is the sole carbon source for
CC       growth.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11.4 uM for isocitrate {ECO:0000269|PubMed:7761851};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11284679,
CC       ECO:0000269|PubMed:2204109, ECO:0000269|PubMed:2682654,
CC       ECO:0000269|PubMed:7761851}.
CC   -!- PTM: Phosphorylation state of this enzyme is controlled by
CC       isocitrate dehydrogenase kinase/phosphatase (AceK).
CC       {ECO:0000269|PubMed:2204109}.
CC   -!- PTM: Succinylation probably inhibits enzymatic activity.
CC       {ECO:0000269|PubMed:21151122}.
CC   -!- SIMILARITY: Belongs to the isocitrate and isopropylmalate
CC       dehydrogenases family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02799; AAA24006.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74220.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35958.1; -; Genomic_DNA.
DR   EMBL; AF017587; AAC45887.1; -; Genomic_DNA.
DR   PIR; A28482; DCECIS.
DR   RefSeq; NP_415654.1; NC_000913.3.
DR   RefSeq; WP_000444484.1; NZ_CP010440.1.
DR   PDB; 1AI2; X-ray; 1.90 A; A=1-416.
DR   PDB; 1AI3; X-ray; 1.90 A; A=1-416.
DR   PDB; 1BL5; X-ray; 2.50 A; A=3-416.
DR   PDB; 1CW1; X-ray; 2.10 A; A=1-416.
DR   PDB; 1CW4; X-ray; 2.10 A; A=1-416.
DR   PDB; 1CW7; X-ray; 2.60 A; A=1-416.
DR   PDB; 1GRO; X-ray; 2.50 A; A=1-416.
DR   PDB; 1GRP; X-ray; 2.50 A; A=1-416.
DR   PDB; 1HJ6; X-ray; 2.00 A; A=1-416.
DR   PDB; 1IDC; X-ray; 2.50 A; A=1-416.
DR   PDB; 1IDD; X-ray; 2.50 A; A=1-416.
DR   PDB; 1IDE; X-ray; 2.50 A; A=1-416.
DR   PDB; 1IDF; X-ray; 2.50 A; A=1-416.
DR   PDB; 1IKA; X-ray; 2.70 A; A=1-416.
DR   PDB; 1ISO; X-ray; 1.90 A; A=1-416.
DR   PDB; 1P8F; X-ray; 1.85 A; A=1-416.
DR   PDB; 1PB1; X-ray; 1.70 A; A=1-416.
DR   PDB; 1PB3; X-ray; 1.70 A; A=1-416.
DR   PDB; 1SJS; X-ray; 2.42 A; A=1-416.
DR   PDB; 3ICD; X-ray; 2.50 A; A=1-416.
DR   PDB; 3LCB; X-ray; 2.90 A; C/D=1-416.
DR   PDB; 4AJ3; X-ray; 1.90 A; A=1-416.
DR   PDB; 4AJA; X-ray; 1.80 A; A=1-416.
DR   PDB; 4AJB; X-ray; 1.90 A; A=1-416.
DR   PDB; 4AJC; X-ray; 2.30 A; A=1-416.
DR   PDB; 4AJR; X-ray; 2.69 A; A=1-416.
DR   PDB; 4AJS; X-ray; 1.80 A; A=1-416.
DR   PDB; 4BNP; X-ray; 2.00 A; A=1-416.
DR   PDB; 4ICD; X-ray; 2.50 A; A=1-416.
DR   PDB; 4P69; X-ray; 3.30 A; C/D=2-416.
DR   PDB; 5ICD; X-ray; 2.50 A; A=1-416.
DR   PDB; 6ICD; X-ray; 2.80 A; A=1-416.
DR   PDB; 7ICD; X-ray; 2.40 A; A=1-416.
DR   PDB; 8ICD; X-ray; 2.50 A; A=1-416.
DR   PDB; 9ICD; X-ray; 2.50 A; A=1-416.
DR   PDBsum; 1AI2; -.
DR   PDBsum; 1AI3; -.
DR   PDBsum; 1BL5; -.
DR   PDBsum; 1CW1; -.
DR   PDBsum; 1CW4; -.
DR   PDBsum; 1CW7; -.
DR   PDBsum; 1GRO; -.
DR   PDBsum; 1GRP; -.
DR   PDBsum; 1HJ6; -.
DR   PDBsum; 1IDC; -.
DR   PDBsum; 1IDD; -.
DR   PDBsum; 1IDE; -.
DR   PDBsum; 1IDF; -.
DR   PDBsum; 1IKA; -.
DR   PDBsum; 1ISO; -.
DR   PDBsum; 1P8F; -.
DR   PDBsum; 1PB1; -.
DR   PDBsum; 1PB3; -.
DR   PDBsum; 1SJS; -.
DR   PDBsum; 3ICD; -.
DR   PDBsum; 3LCB; -.
DR   PDBsum; 4AJ3; -.
DR   PDBsum; 4AJA; -.
DR   PDBsum; 4AJB; -.
DR   PDBsum; 4AJC; -.
DR   PDBsum; 4AJR; -.
DR   PDBsum; 4AJS; -.
DR   PDBsum; 4BNP; -.
DR   PDBsum; 4ICD; -.
DR   PDBsum; 4P69; -.
DR   PDBsum; 5ICD; -.
DR   PDBsum; 6ICD; -.
DR   PDBsum; 7ICD; -.
DR   PDBsum; 8ICD; -.
DR   PDBsum; 9ICD; -.
DR   ProteinModelPortal; P08200; -.
DR   SMR; P08200; -.
DR   DIP; DIP-10006N; -.
DR   IntAct; P08200; 6.
DR   STRING; 511145.b1136; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB02190; 2-Oxalosuccinic Acid.
DR   DrugBank; DB04279; 3-Isopropylmalic Acid.
DR   DrugBank; DB01848; Isocitrate Calcium Complex.
DR   DrugBank; DB01727; Isocitric Acid.
DR   iPTMnet; P08200; -.
DR   SWISS-2DPAGE; P08200; -.
DR   EPD; P08200; -.
DR   PaxDb; P08200; -.
DR   PRIDE; P08200; -.
DR   EnsemblBacteria; AAC74220; AAC74220; b1136.
DR   EnsemblBacteria; BAA35958; BAA35958; BAA35958.
DR   GeneID; 945702; -.
DR   KEGG; ecj:JW1122; -.
DR   KEGG; eco:b1136; -.
DR   PATRIC; 32117521; VBIEscCol129921_1183.
DR   EchoBASE; EB0484; -.
DR   EcoGene; EG10489; icd.
DR   EcoGene; EG10009; icdC.
DR   eggNOG; ENOG4108HMX; Bacteria.
DR   eggNOG; COG0538; LUCA.
DR   HOGENOM; HOG000021113; -.
DR   InParanoid; P08200; -.
DR   KO; K00031; -.
DR   OMA; TERESWI; -.
DR   PhylomeDB; P08200; -.
DR   BioCyc; EcoCyc:ISOCITDEH-SUBUNIT; -.
DR   BioCyc; MetaCyc:ISOCITDEH-SUBUNIT; -.
DR   BRENDA; 1.1.1.42; 2026.
DR   SABIO-RK; P08200; -.
DR   EvolutionaryTrace; P08200; -.
DR   PRO; PR:P08200; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IDA:EcoliWiki.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0004450; F:isocitrate dehydrogenase (NADP+) activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0022900; P:electron transport chain; IMP:EcoliWiki.
DR   GO; GO:0006097; P:glyoxylate cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:EcoCyc.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.718.10; -; 1.
DR   InterPro; IPR019818; IsoCit/isopropylmalate_DH_CS.
DR   InterPro; IPR004439; Isocitrate_DH_NADP_dimer_prok.
DR   InterPro; IPR024084; IsoPropMal-DH-like_dom.
DR   PANTHER; PTHR43504; PTHR43504; 1.
DR   Pfam; PF00180; Iso_dh; 1.
DR   SMART; SM01329; Iso_dh; 1.
DR   TIGRFAMs; TIGR00183; prok_nadp_idh; 1.
DR   PROSITE; PS00470; IDH_IMDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Glyoxylate bypass; Magnesium; Manganese;
KW   Metal-binding; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Tricarboxylic acid cycle.
FT   CHAIN         1    416       Isocitrate dehydrogenase [NADP].
FT                                /FTId=PRO_0000083551.
FT   NP_BIND     339    345       NADP. {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2682654,
FT                                ECO:0000269|PubMed:7761851}.
FT   METAL       307    307       Magnesium or manganese.
FT                                {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2204109,
FT                                ECO:0000269|PubMed:7761851}.
FT   BINDING     104    104       NADP. {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2682654,
FT                                ECO:0000269|PubMed:7761851}.
FT   BINDING     113    113       Substrate. {ECO:0000269|PubMed:3112144}.
FT   BINDING     115    115       Substrate.
FT   BINDING     119    119       Substrate.
FT   BINDING     129    129       Substrate.
FT   BINDING     153    153       Substrate.
FT   BINDING     352    352       NADP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2682654,
FT                                ECO:0000269|PubMed:7761851}.
FT   BINDING     391    391       NADP. {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2682654,
FT                                ECO:0000269|PubMed:7761851}.
FT   BINDING     395    395       NADP. {ECO:0000269|PubMed:11284679,
FT                                ECO:0000269|PubMed:2682654,
FT                                ECO:0000269|PubMed:7761851}.
FT   SITE        160    160       Critical for catalysis.
FT   SITE        230    230       Critical for catalysis.
FT   MOD_RES     100    100       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000269|PubMed:2204109}.
FT   MOD_RES     142    142       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18723842}.
FT   MOD_RES     242    242       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MUTAGEN     100    100       K->R,E: Abolishes enzymatic activity.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MUTAGEN     113    113       S->D,E: Reduced affinity for isocitrate.
FT                                {ECO:0000269|PubMed:2204109}.
FT   MUTAGEN     160    160       Y->F: Large decrease in activity and a
FT                                small increase in substrate affinity.
FT                                {ECO:0000269|PubMed:7761851,
FT                                ECO:0000269|PubMed:7819221}.
FT   MUTAGEN     230    230       K->M: Decrease in activity and substrate
FT                                affinity. {ECO:0000269|PubMed:7761851,
FT                                ECO:0000269|PubMed:7819221}.
FT   MUTAGEN     242    242       K->E: Strongly impairs enzymatic
FT                                activity. {ECO:0000269|PubMed:21151122}.
FT   MUTAGEN     242    242       K->R: Impairs enzymatic activity.
FT                                {ECO:0000269|PubMed:21151122}.
FT   STRAND       15     17       {ECO:0000244|PDB:1PB1}.
FT   STRAND       20     22       {ECO:0000244|PDB:1PB1}.
FT   STRAND       25     32       {ECO:0000244|PDB:1PB1}.
FT   HELIX        38     57       {ECO:0000244|PDB:1PB1}.
FT   STRAND       58     61       {ECO:0000244|PDB:1IKA}.
FT   STRAND       64     67       {ECO:0000244|PDB:1PB1}.
FT   HELIX        72     78       {ECO:0000244|PDB:1PB1}.
FT   HELIX        86     95       {ECO:0000244|PDB:1PB1}.
FT   STRAND       96    100       {ECO:0000244|PDB:1PB1}.
FT   STRAND      107    109       {ECO:0000244|PDB:1PB1}.
FT   HELIX       114    121       {ECO:0000244|PDB:1PB1}.
FT   STRAND      126    132       {ECO:0000244|PDB:1PB1}.
FT   STRAND      140    142       {ECO:0000244|PDB:1PB1}.
FT   HELIX       144    146       {ECO:0000244|PDB:1PB1}.
FT   STRAND      148    154       {ECO:0000244|PDB:1PB1}.
FT   HELIX       158    161       {ECO:0000244|PDB:1PB1}.
FT   STRAND      163    165       {ECO:0000244|PDB:1IDC}.
FT   HELIX       170    181       {ECO:0000244|PDB:1PB1}.
FT   STRAND      196    198       {ECO:0000244|PDB:1IDC}.
FT   HELIX       203    219       {ECO:0000244|PDB:1PB1}.
FT   STRAND      223    229       {ECO:0000244|PDB:1PB1}.
FT   TURN        231    233       {ECO:0000244|PDB:1PB1}.
FT   TURN        235    237       {ECO:0000244|PDB:1PB1}.
FT   HELIX       238    253       {ECO:0000244|PDB:1PB1}.
FT   STRAND      256    258       {ECO:0000244|PDB:1PB3}.
FT   STRAND      259    262       {ECO:0000244|PDB:1IKA}.
FT   STRAND      264    267       {ECO:0000244|PDB:1PB1}.
FT   TURN        269    271       {ECO:0000244|PDB:1PB1}.
FT   STRAND      274    281       {ECO:0000244|PDB:1PB1}.
FT   HELIX       282    291       {ECO:0000244|PDB:1PB1}.
FT   HELIX       293    295       {ECO:0000244|PDB:1PB1}.
FT   STRAND      298    301       {ECO:0000244|PDB:1PB1}.
FT   HELIX       303    316       {ECO:0000244|PDB:1PB1}.
FT   TURN        320    322       {ECO:0000244|PDB:1PB1}.
FT   STRAND      326    328       {ECO:0000244|PDB:1PB1}.
FT   STRAND      333    336       {ECO:0000244|PDB:1PB1}.
FT   HELIX       343    345       {ECO:0000244|PDB:1PB1}.
FT   TURN        346    349       {ECO:0000244|PDB:1IDD}.
FT   HELIX       354    366       {ECO:0000244|PDB:1PB1}.
FT   HELIX       370    385       {ECO:0000244|PDB:1PB1}.
FT   STRAND      388    390       {ECO:0000244|PDB:1GRO}.
FT   HELIX       391    394       {ECO:0000244|PDB:1PB1}.
FT   STRAND      397    399       {ECO:0000244|PDB:1PB1}.
FT   STRAND      401    403       {ECO:0000244|PDB:1GRO}.
FT   HELIX       405    414       {ECO:0000244|PDB:1PB1}.
SQ   SEQUENCE   416 AA;  45757 MW;  9A02E707C3B4FDD9 CRC64;
     MESKVVVPAQ GKKITLQNGK LNVPENPIIP YIEGDGIGVD VTPAMLKVVD AAVEKAYKGE
     RKISWMEIYT GEKSTQVYGQ DVWLPAETLD LIREYRVAIK GPLTTPVGGG IRSLNVALRQ
     ELDLYICLRP VRYYQGTPSP VKHPELTDMV IFRENSEDIY AGIEWKADSA DAEKVIKFLR
     EEMGVKKIRF PEHCGIGIKP CSEEGTKRLV RAAIEYAIAN DRDSVTLVHK GNIMKFTEGA
     FKDWGYQLAR EEFGGELIDG GPWLKVKNPN TGKEIVIKDV IADAFLQQIL LRPAEYDVIA
     CMNLNGDYIS DALAAQVGGI GIAPGANIGD ECALFEATHG TAPKYAGQDK VNPGSIILSA
     EMMLRHMGWT EAADLIVKGM EGAINAKTVT YDFERLMDGA KLLKCSEFGD AIIENM
//
